Home Pancreatic Cancer Study finds why survival remains just 13% after 5 years in pancreatic...

Study finds why survival remains just 13% after 5 years in pancreatic cancer

Credit: Unsplash+

Pancreatic cancer is known as one of the deadliest forms of cancer. It is difficult to detect early, and it often spreads quickly.

Because of this, only a small number of patients survive for many years after diagnosis. Doctors have tried many treatments, but the results have only improved slightly over time.

A new study from Trinity College Dublin is helping to explain why this cancer is so hard to treat. The researchers took a different approach from most earlier studies. Instead of focusing on one small part of the disease, they looked at the whole system. Their work was published in the journal Cancer Letters.

The researchers used a scientific framework called the “Hallmarks of Cancer.” This framework describes the main features that allow cancer to grow and spread. By applying this model to pancreatic cancer, the team was able to map out how different processes work together inside the body.

They found that pancreatic cancer is driven by many connected factors. These include changes in DNA, the environment around the tumor, the way the immune system responds, and how the cancer uses energy. The study also looked at how the cancer interacts with nerves and bacteria in the body.

These different factors do not act alone. They work together in a coordinated way, making the cancer stronger and more resistant to treatment. This helps explain why many drugs that target only one pathway have not been successful.

By reviewing hundreds of studies, the researchers created a detailed overview of the disease. This allowed them to see patterns and connections that were not clear before. It also helped them identify areas where more research is needed.

One important conclusion is that future treatments will likely need to be more complex. Instead of using one drug, doctors may need to use combinations of treatments that target several parts of the cancer at the same time. This approach may be more effective in slowing down or stopping the disease.

The study also suggests that clinical trials should be designed in a new way. Using biomarkers to guide treatment decisions may help doctors choose the best therapy for each patient. In addition, better laboratory models are needed to study how the cancer behaves in real life.

For patients, this research offers a better understanding of why pancreatic cancer is so difficult to treat. It also shows that scientists are working on new ideas that may lead to better therapies in the future.

When reviewing the findings, the study stands out because it brings together a large amount of knowledge into one clear system. This is very useful for guiding future research. However, it does not provide direct evidence of new treatments yet. More studies are needed to test these ideas in real patients.

In summary, this research shows that pancreatic cancer is a complex disease that requires a more advanced approach. By understanding how all parts of the disease work together, scientists can develop smarter and more effective treatments. This could lead to better outcomes for patients in the future.

If you care about cancer, please read studies that a low-carb diet could increase overall cancer risk, and berry that can prevent cancer, diabetes, and obesity.

For more health information, please see recent studies about how drinking milk affects the risks of heart disease and cancer and results showing vitamin D supplements could strongly reduce cancer death.

Source: Trinity College Dublin.